GPBAR1 and myeloid sarcoma: Concomitantly, TGR5 agonists, antagonizing FXR can stimulate adipose tissue thermogenesis, boost energy metabolism, and reduce inflammation.154 Moreover, they have been reported to alleviate obesity and MS in mouse models.155